Pharmaceutical Industry Blog

Last Updated: July 24, 2026 TL;DR: Venezuela is a market of roughly 28 to 29 million residents — after an emigration of some 7.7 million people — where a prolonged humanitarian and economic crisis has hollowed out both public procurement and domestic manufacturing, leaving deep, genuine demand for affordable sterile injectables. Local production fell by around 70% over the crisis and the industry now depends on imports for roughly 98% of its inputs; medicine shortages reached

Last Updated: July 24, 2026 TL;DR: Cameroon is a market of roughly 30 to 31 million people that imports the overwhelming majority of the medicines it consumes — local production covers only about 5% and there is no domestic maker of small-volume sterile injectables. Demand is heavy: Cameroon is one of the world’s eleven High Burden to High Impact malaria countries, with an estimated 7.6 million cases and around 11,700 deaths in 2024; cancer already accounts for roughly 19,600

Last Updated: July 22, 2026 TL;DR: Nepal is a market of close to 30 million people that imports well over half of the medicines it consumes and depends on India for the overwhelming majority of those imports — India also supplies effectively all of the active pharmaceutical ingredients Nepali factories use. Demand for sterile injectables is driven by a striking epidemiological shift: non-communicable diseases now account for roughly 71% of deaths, cardiovascular disease alone

Last Updated: July 22, 2026 TL;DR: Côte d’Ivoire is a market of roughly 32 million people that imports more than 90% of the medicines it consumes, with local production covering only about 6% and no domestic maker of small-volume sterile injectables. Demand is heavy: the country is among the world’s highest-burden malaria nations, with an estimated 7.8 million cases and around 10,800 deaths a year; maternal mortality stands at 480 per 100,000 live births; and cancer already a

Last Updated: July 21, 2026 TL;DR: Madagascar is a market of roughly 33.5 million people in which essentially every sterile injectable is imported. The national regulator's own register of licensed manufacturers lists just three companies — FARMAD, HOMEOPHARMA and PHARMALAGASY — and none of them produces sterile injectables. Demand is severe and rising: malaria cases quadrupled between 2019 and 2024 to an estimated 8.17 million with 20,903 deaths, maternal mortality stands at

Last Updated: July 21, 2026 TL;DR: Peru is a market of roughly 35 million people that imports around two-thirds of the medicines it consumes, with domestic production estimated at about a third of the total and shrinking. Cancer is now the country's leading cause of death, anaemia affects 43.4% of children aged 6 to 35 months, and tuberculosis notifications reached 33,049 in 2024 — all of which sustain steady demand for sterile injectables across oncology, anti-infectives, pa